Format

Send to

Choose Destination
IET Nanobiotechnol. 2018 Aug;12(5):549-556. doi: 10.1049/iet-nbt.2017.0242.

Nanotechnological approaches for the development of herbal drugs in treatment of diabetes mellitus - a critical review.

Author information

1
Nanotechnology Laboratory, Institute of Frontier Technology, Regional Agricultural Research Station, Acharya N. G. Ranga Agricultural University, Tirupati 517 502, AP, India.
2
Nanotechnology Laboratory, Institute of Frontier Technology, Regional Agricultural Research Station, Acharya N. G. Ranga Agricultural University, Tirupati 517 502, AP, India. tnvkvprasad@gmail.com.

Abstract

Diabetes mellitus (DM) is a chronic illness that requires continuing medical care and patient self-management education to prevent acute complications and to reduce the risk of long-term complications. The number of people with diabetes is increasing due to population growth, ageing, urbanisation and increasing prevalence of obesity and physical inactivity. Apart from currently available therapeutic options, many herbal medicines have been recommended for the treatment of diabetes. Herbal drugs are prescribed widely because of their effectiveness, less side effects and relatively low cost. Several pharmacopoeias have provided parameters to maintain quality and standardise procedures in identification/authentication of herbal inputs and their products. Available literature related to folklore medicine used in the treatment of diabetes extended to nanoformulation of herbal drugs up to date was cited. The use of bioactive compounds leads to new hope to improve the life expectancy and health status of the population for the formulation of novel drugs. Recently, many studies have shown that nanotechnology has the potential to be used in different biological and medical applications, mainly as targeted drug delivery systems to minimise and delay the chronic effects of diabetes. Herein, the authors presented a thorough review of the available herbal medicines and the possibilities of developing their nanoformulations in the treatment of DM.

PMID:
30095411
DOI:
10.1049/iet-nbt.2017.0242
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center